Evidence map›Paper›PMID 42740094›Full record

ArticleSensors (Basel, Switzerland)2026

Coherent Target Cancellation and Deceptive Jamming Through a Multi-Region Time-Coding Metasurface.

Chen Zhang, Wenjuan Qi, Xu Qi, Zhifeng Cheng, Xuekai Lan, Lirui Xu, Diwei Liu

Abstract read
In one paragraph

Article in Sensors (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Chen ZhangNaval University of Engineering, Wuhan 430033, China.
Wenjuan QiNaval University of Engineering, Wuhan 430033, China.
Xu QiNaval University of Engineering, Wuhan 430033, China.
Zhifeng ChengNaval University of Engineering, Wuhan 430033, China.
Xuekai LanNaval University of Engineering, Wuhan 430033, China.
Lirui XuNaval University of Engineering, Wuhan 430033, China.
Diwei LiuTerahertz Science and Technology Research Center, University of Electronic Science and Technology of China, Chengdu 610054, China.

Funding

National Natural Science Foundation of China 62401603
6 · The paper itself

Abstract

Existing metasurface-based radar countermeasures commonly manipulate echoes from metasurface-covered regions, whereas protecting exposed scattering centers that cannot accommodate metasurfaces remains challenging. This paper presents a multi-region time-coding metasurface (MRTCM) architecture for coherent target cancellation and deceptive jamming. The proposed system uses multiple independently controlled metasurface regions distributed over available platform surfaces. Each region generates zeroth-order and higher-order harmonic components through periodic phase modulation, and these components coherently combine with echoes from uncovered areas. The zeroth-order component is invariant under cyclic shifts of the coding sequence, enabling stable cancellation during multi-pulse coherent processing without locking radar-pulse arrival to the start of the coding cycle. Higher-order harmonics can shift the apparent range of the metasurface response and support cancellation at range-separated cells, but require accurate timing and synchronization. Numerical simulations demonstrate more than 40 dB suppression in high-resolution range profiles and validate the cancellation behavior under moving-target detection processing. The MRTCM architecture therefore provides a theoretically grounded framework for electromagnetic protection when full metasurface coverage is impractical.

Indexed as

coherent cancellationdeceptive jammingmulti-region time-coding metasurface (MRTCM)radar countermeasures

Identifiers

PMID42740094
PMCPMC13567946

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.